Amiodarone-induced skin hyperpigmentation

QJM: An International Journal of Medicine

Volumn 104, Issue 8, 2011, Pages 723-724

  Stahli B E ^a   Schwab, S ^a  

^a Spital Region Oberaargau   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; LIPOFUSCIN; ANTIARRHYTHMIC AGENT;

AGED; CASE REPORT; DRUG INDUCED DISEASE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; LYSOSOME; MAINTENANCE DRUG DOSE; MALE; MEDICAL HISTORY; NOTE; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; ARTICLE; CHEMICALLY INDUCED DISORDER; FACE; HAND;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FACE; HAND; HUMANS; HYPERPIGMENTATION; MALE;

EID: 84855752226     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq131     Document Type: Note

References (3)

1. Harris L, McKenna WJ, Rowland E, Holt DW, Storey GCA, Krikler DM. Side effects of long-term amiodarone therapy. Circulation 1983; 67: 45-51.
2. Blackshear JL, Randle HW. Reversibility of blue-gray cutaneous discoloration from amiodarone. Mayo Clin Proc 1991; 66: 721-6.
3. Rappersberger K, Hönigsmann H, Ortel B, Tanew A, Konrad K, Wolff K. Photosensitivity and hyperpigmentation in amiodarone-treated patients: incidence, time course, and recovery. J Invest Dermatol 1989; 93: 201-9.